Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZETELD: Ezetimibe + Atorvastatin vs Atorvastatin Titration in Elderly
NCT00418834Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Percent Change From Baseline in LDL-C at Week 6. Started Jan 2007; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00418834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418834.